NEW YORK (Reuters Health) – The response of adolescents with migraine to treatment with combination sumatriptan and naproxen sodium is similar to that seen in adults, with no…
NEW YORK (Reuters Health) – Intensive treatment of type 2 diabetes that’s detected early through screening does not seem to reduce rates of subsequent complications, a Danish study…
NEW YORK (Reuters Health) – For patients with inadequately controlled asthma, the combination of mometasone furoate and formoterol reduces exacerbations and slows the decline in lung function more…
NEW YORK (Reuters Health) – Biweekly injections of pegloticase may quickly lower uric acid and ease symptoms in some gout patients who don’t get better with usual treatment,…
NEW YORK (Reuters Health) – Among patients undergoing cardiac procedures, a lower dose of contrast medium based on calculated creatinine clearance may reduce the risk of contrast-induced nephropathy,…
NEW YORK (Reuters Health) – An updated guideline on the management of chronic heart failure by the UK’s National Institute for Health and Clinical Excellence (NICE) addresses changes…
NEW YORK (Reuters Health) – An analysis of the sensitivity of several diagnostic tests for histoplasmosis indicates that combining antigen and antibody testing, as well as culture and…
NEW YORK (Reuters Health) – For best results, laparoscopic cholecystectomy in patients with acute cholecystitis should be performed within 48 hours of hospital admission, a Swiss team reports.…
NEW YORK (Reuters Health) – A novel glucose-lowering drug, dapagliflozin, improves glycemic control in patients with type 2 diabetes already on metformin, and it promotes significant weight loss,…
NEW YORK (Reuters Health) – Algorithms based on procalcitonin (PCT) measurements reduce the use of antibiotics without jeopardizing patient safety, according to a review of randomized clinical trials.…
